Hexo Corp Closes Acquisition Of Zenabis Global

HEXO Corp. (TSX: HEXO) announced today the closing of the acquisition of all issued and outstanding shares of Zenabis Global Inc. (TSX: ZENA). Zenabis shares are expected to be delisted from the Toronto Stock Exchange when markets close on June 2, 2021.

Under the terms of the acquisition, each Zenabis shareholder is now entitled to receive 0.01772 of a HEXO common share for each Zenabis share held. Warrants to purchase Zenabis shares are also exercisable after the acquisition, albeit it will now be in HEXO shares for the same consideration exchange.

Zenabis also has an outstanding class of warrants listed on the TSX under the symbol “ZENA.WT”. These listed warrants will continue to trade under the new symbol “HEXO.WT” starting June 3, 2021.

HEXO Corp. last traded at $8.61 while Zenabis Global Inc. last traded at $0.145 on the TSX.


Information for this briefing was found via Sedar and Hexo Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rod Husband

Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Related News

Will The Medipharm Labs Statement Of Claim Cause Further Issue For Hexo Corp?

It’s been revealed today by that of BNN Bloomberg that Medipharm Labs’ (TSX: LABS) statement...

Monday, January 27, 2020, 08:30:12 PM

Hexo Sees St-Louis Step Down As Director

After just one month of stepping down from the role of Chief Executive Officer, Hexo...

Friday, November 19, 2021, 09:03:27 AM

Hexo Has Filed A $35 Million Counterclaim Against Medipharm Labs

It appears that Hexo Corp (TSX: HEXO) (NYSE: HEXO) has filed a counterclaim against Medipharm...

Thursday, June 18, 2020, 11:48:39 AM

Canaccord Raises Sundial’s Price Target To $0.40, Casts Doubt On Zenabis

After a very busy and dilutive December, where shares outstanding went from 485.5 million to...

Monday, January 4, 2021, 11:11:00 AM

Hexo Posts Fourth Quarter Revs of $15.4 Million, Loss of $56.7 Million

Hexo Corp (TSX HEXO) (NYSE: HEXO) filed its interim financial statements for the fourth quarter...

Monday, October 28, 2019, 11:24:04 PM